LAA Excision With AF Ablation Versus Oral Anticoagulants for Secondary Prevention of Stroke
- Conditions
- StrokeSystemic EmbolismAtrial Fibrillation
- Interventions
- Procedure: Thoracoscopic LAA Excision plus AF Ablation
- First Posted Date
- 2015-06-23
- Last Posted Date
- 2019-04-23
- Target Recruit Count
- 474
- Registration Number
- NCT02478294
- Locations
- 🇨🇳
The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Plasma and Platelet microRNAs in Clopidogrel Low Response Patients
- Conditions
- Coronary Artery Disease
- Interventions
- Drug: acetylsalicylic acid (ASA)
- First Posted Date
- 2015-05-19
- Last Posted Date
- 2016-02-15
- Target Recruit Count
- 400
- Registration Number
- NCT02447809
- Locations
- 🇨🇳
First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Incidence of Pulmonary Embolism During Temporary Pacing Via Femoral Versus Subclavian Vein
- Conditions
- Pulmonary Embolism
- First Posted Date
- 2015-04-30
- Last Posted Date
- 2016-02-19
- Target Recruit Count
- 360
- Registration Number
- NCT02430207
Reversal of the Anti-platelet Effects of Ticagrelor
- Conditions
- Coronary Artery Disease
- Interventions
- First Posted Date
- 2015-03-09
- Last Posted Date
- 2017-08-16
- Target Recruit Count
- 64
- Registration Number
- NCT02383771
- Locations
- 🇨🇳
First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Pharmacogenetic and Pharmacokinetic Study of Clopidogrel
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2013-10-24
- Last Posted Date
- 2017-10-18
- Target Recruit Count
- 1805
- Registration Number
- NCT01968499
- Locations
- 🇨🇳
First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial
- Conditions
- Coronary Artery Disease
- Interventions
- First Posted Date
- 2013-10-07
- Last Posted Date
- 2020-08-18
- Target Recruit Count
- 1724
- Registration Number
- NCT01955200
- Locations
- 🇨🇳
First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease
- First Posted Date
- 2013-08-19
- Last Posted Date
- 2013-08-20
- Target Recruit Count
- 40
- Registration Number
- NCT01925352
- Locations
- 🇨🇳
Jiangsu Province Hospital, Nanjing, Jiangsu, China
Study of Segmental Renal Artery Clamping During Laparoscopic Partial Nephrectomy
- Conditions
- Kidney NeoplasmsRenal Cell Carcinoma
- First Posted Date
- 2013-07-03
- Last Posted Date
- 2013-07-03
- Target Recruit Count
- 100
- Registration Number
- NCT01892059
- Locations
- 🇨🇳
Department of Urology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
The Influence of Walking at Different Times of Day on Blood Lipids and Inflammatory Markers
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2013-06-26
- Last Posted Date
- 2013-06-27
- Target Recruit Count
- 330
- Registration Number
- NCT01887093
- Locations
- 🇨🇳
Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Trial of DA-EPOCH Regimen for NHL With HLH
- Conditions
- NHL With Hemophagocytic Lymphohistiocytosis
- Interventions
- Drug: DA-EPOCH
- First Posted Date
- 2013-03-27
- Last Posted Date
- 2019-02-15
- Target Recruit Count
- 50
- Registration Number
- NCT01818908
- Locations
- 🇨🇳
ChangZhou No.2 People's Hospital, ChangZhou, Jiangsu, China
🇨🇳HuaiAn First People's Hospital, HuaiAn, Jiangsu, China
🇨🇳JiangSu Province Hospital, NanJing, Jiangsu, China